Sofija Jovic, PhD, MBA

Business Transformation Advisor


Photo of Sofija Jovic

Dr. Jovic joined WCG in 2017 when WCG acquired ProPhase, a leading global provider of specialized tools to support measurement-related activities in clinical trials. She now serves as a member of WCG’s MedAvante-ProPhase executive team.

Dr. Jovic led ProPhase as co-founder, CEO and managing board member for more than 10 years, transforming it from a start up to a market leader. ProPhase’s portfolio includes electronic clinical outcome assessments and endpoint surveillance solutions, rater training and certification, and study start-up support.

Keen to share her knowledge, Dr. Jovic serves as a member of the board at Inflexxion Inc., CRA Assessments, and Gilda’s Club of New York City.

An active supporter of both CNS-related organizations and women entrepreneurs, Dr. Jovic is a member of CNS Summit, The International Society for CNS Drug Development, Women in BIO, Women Entrepreneurs in Science and Technology, and the Healthcare Businesswomen’s Association.

Dr. Jovic was recently named a National Association of Corporate Directors Board Leadership™ Fellow and one of the top 20 life science executives poised for board service by the Women in BIO Boardroom Ready program. She also serves on Springboard’s Life Science Council, an invitation-only group of professionals who support women entrepreneurs seeking resources to grow companies they lead.

Dr. Jovic received her PhD in clinical psychology from Long Island University and her MBA from MIT.